PMC:7291971 / 34074-34217
Annnotations
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T716 | 9-17 | CHEBI:36357;CHEBI:36357 | denotes | compound |
| T717 | 115-125 | SP_7 | denotes | SARS-CoV-2 |
| T718 | 126-131 | PR:000000125 | denotes | nsp14 |
| T719 | 132-142 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
| T14527 | 9-17 | CHEBI:36357;CHEBI:36357 | denotes | compound |
| T75722 | 115-125 | SP_7 | denotes | SARS-CoV-2 |
| T45819 | 126-131 | PR:000000125 | denotes | nsp14 |
| T90350 | 132-142 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T97 | 115-123 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T563 | 132-142 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T243 | 0-143 | Sentence | denotes | The lead compound 13 and the most potent derivatives will serve as starting building blocks for the development of SARS-CoV-2 nsp14 inhibitors. |